NCT06338020Completed
Adaptive Variable-Resistance Training in Pediatric Survivors of Acute Lymphoblastic Leukemia
Effects of Adaptive Variable-resistance Training on Chemotherapy-induced Sarcopenia, Fatigue, and Functional Restriction in Pediatric Survivors of Acute Lymphoblastic Leukemia: A Large-scale Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 29 Mar 2024
Brief summary (registry, in English)
This study was designed to investigate the effect of eight weeks of adaptive variable-resistance training (Adaptive-VRT) on chemotherapy-induced sarcopenia, fatigue, and functional restrictions in a convenience sample of pediatric survivors of acute lymphoblastic leukemia (ALL). Sixty-two pediatric survivors of ALL were randomly allocated to the experimental group (n = 31, received the adaptive variable-resistance training) or the Control group (n = 31, received standard physical therapy care). Both groups were assessed for muscle mass, strength, fatigue, and functional capacity before and after treatment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 62 (actual)
- First submitted
- 23 Mar 2024
- Start date
- 29 Dec 2022
- Primary completion date
- 4 Jan 2024
- Lead sponsor
- Cairo University
- NCT number
- NCT06338020
What you commit to
- Study type: Interventional
- Participants enrolled: 62
- From 29 Dec 2022 to the primary completion date, 4 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Secondary cancers
- Neuro-musculoskeletal conditions are likely to impede the training.
Other
- Neurodegenerative impairments affecting memory, attention, or executive functioning
Who the study is looking for
- Age between 12 and 18 years old
- Complete maintenance chemotherapy
- Secondary sarcopenia
- Normal cardiac structure and function
- Absence of lower limb deformities
- Not engaging in regular exercise regimens
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ragab K. Elnaggar Coordinator of this site? Confirm its status | Al Kharj | Saudi Arabia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.